Estrogen-replacement therapy after breast cancer risks versus benefits
- 15 March 1993
- Vol. 71 (S6) , 2169-2176
- https://doi.org/10.1002/1097-0142(19930315)71:6+<2169::aid-cncr2820711608>3.0.co;2-b
Abstract
No abstract availableKeywords
This publication has 25 references indexed in Scilit:
- Postmenopausal Estrogen Therapy and Cardiovascular DiseaseNew England Journal of Medicine, 1991
- Oncogenic potential of tamoxifen on endometria of postmenopausal women with breast cancer—Preliminary reportGynecologic Oncology, 1991
- ESTROGEN REPLACEMENT THERAPY: IS PREVIOUSLY TREATED CANCER A CONTRAINDICATION?Obstetrics & Gynecology, 1991
- Effects of Tamoxifen Therapy on Lipid and Lipoprotein Levels in Postmenopausal Patients With Node-Negative Breast CancerJNCI Journal of the National Cancer Institute, 1990
- The effect of female sex hormones on cancer survival. A register-based study in patients younger than 20 years at diagnosisJAMA, 1990
- Tamoxifen for breast cancer: Associated endometrial cancerCancer, 1990
- Menopause and Risk Factors for Coronary Heart DiseaseNew England Journal of Medicine, 1989
- Hormones and breast cancerThe American Journal of Surgery, 1989
- Menopause and the Risk of Coronary Heart Disease in WomenNew England Journal of Medicine, 1987
- The ClimactericPublished by Springer Nature ,1983